Contact UsCareersNewsScienceContact Us

Helping protect people from life-threatening illnesses

HomeOur ScienceFocus AreasVaccine

We help protect as many people as possible from life-threatening illness with quality vaccines that make an impact across all stages of life.1

In India, as of 2010, pneumococcal disease took the life of 1 child every 2 minutes.2 According to a study, there were an estimated 0.56 million severe episodes of pneumococcal disease annually and 105,000 pneumococcal deaths in children under 5 years2. Pneumococcal disease is a major public health concern for older adults as well, particularly those with chronic conditions such as heart disease, respiratory disease and elevated blood sugar levels. 3

For over 20 years, Pfizer has been helping protect as many people as possible from one of the world’s most pernicious vaccine-preventable illnesses: pneumococcal disease, which includes lung, ear and brain infections. 4

Passion drives us

Our passion for science, for delivering excellence and for people’s health drives bold advancements in Research and Design (R&D) and high-quality manufacturing to consistently make a meaningful impact on public health. Passion drives our organization and permeates everything we do.​​​​​​​

We also carry out education programs for health care professionals as per recommendations of the Indian societies. Using digital channels and social media we reach out to millions to address common concerns and promote the well-being of all age groups.

Via multiple access and awareness initiatives for healthcare professionals and paramedics in pediatric and elderly settings, we continue to drive scientific conversations and share latest updates on vaccines.

Every day, we work toward a healthier world by inventing, developing and championing vaccines, which provide essential health benefits to people of all ages.


1.; last accessed on 22nd September 2021
2. GAVI | Pneumococcal disease: the leading vaccine-preventable cause of death in children under five available at: [last accessed on: 22nd September, 2021]
3. Torres A, Blasi F, Dartois N, Akova M. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax. 2015 Oct 1;70(10):984-9.
4.; last accessed on 22nd September 2021


This information—including product information—is intended only for residents of India. The products discussed herein may have different labelling in different countries. Patients should always ask their doctors for medical advice.

PP-CPF-IND-0035 | 11/11/21

About UsOur ScienceOur Community EffortsYour Health Career-Seekers News & MediaHealthcare ProfessionalsContact UsTerms And ConditionsPrivacy PolicyAdverse Event ReportingCopyright © 2002- 2022 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of  India and strictly only for informational, educational, academic and/or research purposes and is not intended to substitute for professional medical advice, diagnosis or treatment. While due care and caution has been taken to ensure that the content here is free from mistakes or omissions, Pfizer makes no claims, promises or guarantees about the accuracy, completeness or adequacy of the information here. You may report an adverse event related to Pfizer products by emailing us at or via Fax at: 000800100-5961 / +91-22 3919-771.